VERONICA AGUIRRI: Open Payments
NPI 1265200075 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$667 in 25 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $617 · 2025 $667
Food & beverage: $667
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $151 |
| ABBVIE INC. | 8 | $138 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| Amgen Inc. | 2 | $107 |
| Novo Nordisk Inc | 3 | $55 |
| Seqirus USA Inc | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: VRAYLAR, Kerendia, AIRSUPRA, REPATHA, Flucelvax, FARXIGA, BREZTRI, REXULTI.
Industry payments across TX — which companies pay providers there.
